hypoglycemia and semaglutide Is it safe to start low‑dose (Wegovy) for weight loss in a patient with severe reactive who is taking metformin (Proglycem 75 mg daily)? Comparative safety and side effects
Description
Post-market surveillance and real-world observational studies have not documented a causal link between semaglutide use and thyroid nodule formation or malignancy in humans
Journal of Clinical Endocrinology & Metabolism
When GLP-1s normal daily pattern is disturbed, it may impair glucose regulation and increase the risk of metabolic conditions
Thats real money that makes the difference between affording treatment or going without
It exists within a weight management protocol that involves far more than a weekly injection
